Temocillin use as a carbapenem-sparing option in a UK teaching hospital for treating serious Gram-negative bacterial infections.

Enoch, D A; Murphy, M E; Gouliouris, T; Santos, R; Micallef, C

Enoch, D A; Murphy, M E; Gouliouris, T; Santos, R; Micallef, C.

Afiliação

Enoch DA; Clinical Microbiology & Public Health Laboratory, UK Health Security Agency, Addenbrooke's Hospital, Hills Road, Cambridge CB2 OQW, UK.
Murphy ME; Department of Microbiology, UKNHS GGC Glasgow Royal Infirmary, New Lister Building, Alexandra Parade, Glasgow G31 2ER, UK.
Gouliouris T; Clinical Microbiology & Public Health Laboratory, UK Health Security Agency, Addenbrooke's Hospital, Hills Road, Cambridge CB2 OQW, UK.
Santos R; Department of Pharmacy, Addenbrooke's Hospital, Hills Road, Cambridge CB2 OQQ, UK.
Micallef C; Department of Pharmacy, Addenbrooke's Hospital, Hills Road, Cambridge CB2 OQQ, UK.

JAC Antimicrob Resist ; 4(5): dlac111, 2022 Oct.

Article em En | MEDLINE | ID: mdl-36324332

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: JAC Antimicrob Resist Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido